// 聯合創始人、科大化學及生物工程學系教授周迎指出，目前藥廠主要採用膠粒（plastic bead）培育免疫細胞，惟膠粒與人類細胞非常不同，難以傳遞正確指令；團隊採用的生物材料則與細胞更接近，有助於與之接觸及互動，更易於培養數量足夠的細胞
Co-founder and professor of the Department of Chemical and Biological Engineering at HKUST, Dr. Zhou Ying, pointed out that currently, pharmaceutical companies mainly use plastic beads to cultivate immune cells. However, plastic beads are very different from human cells and it is difficult to transmit accurate instructions. The team uses bio-materials that are closer to cells, which facilitates contact and interaction with cells and makes it easier to cultivate a sufficient quantity of cells. http://startupbeat.hkej.com/?p=134845 //